Vineti secures new patent from USPTO for individualized medicine platform
23 mars 2022 09h00 HE
|
Vineti
SAN FRANCISCO, March 23, 2022 (GLOBE NEWSWIRE) -- Vineti, Inc., the provider of the leading digital platform of record for cell and gene therapies, today announced that the United States Patent and...
Vineti Appoints Ann Klein as Chief Executive Officer
04 mars 2022 10h00 HE
|
Vineti
SAN FRANCISCO, March 04, 2022 (GLOBE NEWSWIRE) -- Vineti, Inc., the provider of the leading digital platform of record for personalized therapeutics, today announced the appointment of Ann Klein as...
Vineti achieves SOC2 Type II compliance
26 janv. 2022 09h00 HE
|
Vineti
Vineti further demonstrates its ongoing commitment to enterprise-grade security, privacy, and compliance for its biopharmaceutical customers working in cell and gene therapies.Successful completion of...
Vineti introduces new PTM® Integration Suite: purpose-built connectivity and interoperability for cell and gene therapies
10 janv. 2022 09h00 HE
|
Vineti
New PTM® Integration Suite brings a purpose-built integration solution to highly complex, distributed cell and gene therapy workflows. Focused on secure interoperability for patient-related data,...
Be The Match BioTherapies® and Vineti collaborate to develop innovative, integrated supply chain management solutions for cell and gene therapies
08 déc. 2021 06h30 HE
|
Vineti
MINNEAPOLIS and SAN FRANCISCO, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Be The Match BioTherapies®, an organization offering solutions for companies developing and commercializing cell and gene therapies...
Autolomous and Vineti form strategic partnership to deliver end to end supply chain management solutions for cell and gene therapy sector
19 oct. 2021 06h00 HE
|
Vineti
LONDON and SAN FRANCISCO, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Autolomous LTD, the market leading developer of critical manufacturing management systems for cell and gene therapies, and Vineti, a...
Körber and Vineti Announce Partnership to Provide Improved Manufacturing Performance and Visibility Globally for Cell and Gene-Based Therapies
12 oct. 2021 03h05 HE
|
Vineti
Körber is the world’s leading supplier of manufacturing execution systems (MES) and manufacturing IT solutions for the pharmaceutical and biopharmaceutical industries.Vineti provides the leading...
Lykan Bioscience and Vineti Announce Partnership to Advance Cell-based Therapies from Clinical to Commercialization
12 août 2021 09h00 HE
|
Vineti
HOPKINTON, Mass. and SAN FRANCISCO, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Lykan Bioscience, a contract development and manufacturing organization (CDMO) focused on cell-based therapies, and Vineti, the...
Vineti announces agreement with Imvax to utilize Vineti's PTM Essentials™ solution
10 août 2021 07h00 HE
|
Vineti
SAN FRANCISCO, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Vineti, Inc., the leading enterprise software platform of record for personalized therapeutics, today announced an agreement with Imvax, Inc. to...
Ori Biotech and Vineti Form Strategic Partnership to Deliver Integrated Manufacturing and Supply Chain Solutions for Cell and Gene Therapies
26 mai 2021 03h05 HE
|
Vineti
LONDON and SAN FRANCISCO, May 26, 2021 (GLOBE NEWSWIRE) -- Ori Biotech, an innovator in cell and gene therapy manufacturing, and Vineti, a provider of leading digital enterprise platforms for cell...